predictXbio
1 known investors
PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
AI & Machine LearningBiotechDeep Tech
Founders & leadership
CK
Cory Kromer-EdwardsFounder/CEO
RD
Russ DondaChief Strategy Officer
Investors · 1
Frequently asked questions
- What does predictXbio do?
- PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
- Who founded predictXbio?
- predictXbio was founded by Cory Kromer-Edwards.
- Who are predictXbio's investors?
- predictXbio's investors include JumpStart Equity.